Zhu Rui-Xia, Song Chun-Hui, Yang Jin-Shan, Yi Qing-Ting, Li Bao-Jian, Liu Si-Hai
Department of Oncology, Central Hospital of Zaozhuang Mineral Group, Zaozhuang, Shandong 277800, P.R. China.
Mol Med Rep. 2016 Sep;14(3):2846-52. doi: 10.3892/mmr.2016.5579. Epub 2016 Aug 1.
The deregulation of microRNAs (miRNAs) is often implicated in the control of sensitivity to radiotherapy. The objective of the present study was to identify the association between miR‑558 and apoptosis‑associated tyrosine kinase (AATK), and their importance in regulating the development of resistance to radiotherapy. The current study demonstrated that AATK, a radiosensitization-associated gene, is a target of miR‑558 in lung cancer cells, using in silico analysis and a luciferase reporter system. Furthermore, it was determined that transfection of 30 or 50 nM miR‑558 mimics and AATK specific siRNA markedly suppressed the mRNA and protein expression of AATK. To determine whether miR‑558 was required for lung cancer cell radioresistance, A549 cells were treated with different doses of ionizing radiation, from 0 to 10 Gy, following transfection with miR‑558 mimics or AATK specific siRNA. It was determined that the administration of miR‑558 mimics or AATK specific siRNA alone did not significantly alter the survival rate of the cells. By contrast, in the cells exposed to 4, 6 or 8 Gy, the administration of miR‑558 mimics or AATK specific siRNA significantly promoted cell survival rate and overexpression of AATK reversed this effect. In conclusion, these data demonstrate that the miR‑558/AATK cascade is important for the radiosensitization of lung cancer cells and may be a potential radiotherapy target.
微小RNA(miRNA)的失调常与放射治疗敏感性的控制有关。本研究的目的是确定miR-558与凋亡相关酪氨酸激酶(AATK)之间的关联,以及它们在调节放射治疗抗性发展中的重要性。当前研究通过计算机分析和荧光素酶报告系统证明,放射增敏相关基因AATK是肺癌细胞中miR-558的靶标。此外,已确定转染30或50 nM的miR-558模拟物和AATK特异性siRNA可显著抑制AATK的mRNA和蛋白表达。为了确定miR-558是否是肺癌细胞放射抗性所必需的,在用miR-558模拟物或AATK特异性siRNA转染后,将A549细胞用0至10 Gy的不同剂量电离辐射处理。已确定单独施用miR-558模拟物或AATK特异性siRNA不会显著改变细胞的存活率。相比之下,在暴露于4、6或8 Gy的细胞中,施用miR-558模拟物或AATK特异性siRNA可显著提高细胞存活率,而AATK的过表达可逆转这种作用。总之,这些数据表明miR-558/AATK级联对于肺癌细胞的放射增敏很重要,可能是一个潜在的放射治疗靶点。